search
Back to results

Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used (ASGE)

Primary Purpose

Colonoscopy, Polyp of Colon

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
CAP-straight
CAP-daisy
water
Sponsored by
VA Greater Los Angeles Healthcare System
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Colonoscopy focused on measuring colonoscopy, adenoma detection rate, caps

Eligibility Criteria

50 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Male and female 50-75 yrs of age.
  2. Positive screening for Fecal Immunochemical Test (FIT) or Fecal Occult Blood Test (FOBT).
  3. Subjects willing to undergo routine screening and surveillance colonoscopy.

Exclusion Criteria:

  1. Patients who decline to provide informed consent.
  2. Patients known to have colonic obstruction, inflammatory bowel disease, or active GI bleeding requiring interventions.
  3. Patients know to have prior history of severe diverticulitis/diverticulosis.

Sites / Locations

  • Sacramento VAMC, VA Northern California Healthcare SystemRecruiting
  • Veterans Affairs Palo Alto Healthcare SystemRecruiting
  • Xijing Hospital of Digestive DiseasesRecruiting
  • St. Barbara Hospital
  • Dalin Tzu Chi General HospitalRecruiting
  • Hualien Tzu Chi HospitalRecruiting
  • Evergreen General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Water

CAP-straight

CAP-daisy

Arm Description

Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.

A straight transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.

A daisy cap transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Note: IRB Approval date for the use of Endocuff at St. Barbara Hospital, Iglesias (CA), Italy, was obtained on 3/8/2017. IRB Approval date for the use of Endocuff at Evergreen General Hospital, Taipei, Taiwan, was obtained on 3/18/2021.

Outcomes

Primary Outcome Measures

Adenoma detection rate
The proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas, or polyps, detected.

Secondary Outcome Measures

Cecal intubation
Visualization of ileocecal valve/appendix orifice and the medial wall of the cecum with colonoscope tip touching floor of cecum
Boston bowel preparation score
Three segments (Right, transverse, left colon), each with 0 to 3 (poor to excellent); total scores = sum (10 point scale)
Cecal intubation time
Total time from insertion into the anus to arrival in the cecum
Visual analogue scale (0=not satisfied, 10=very satisfied)
Patient satisfaction
Willing to repeat
Visual analogue scale (0=not willing, 10=willing)

Full Information

First Posted
April 30, 2018
Last Updated
October 4, 2022
Sponsor
VA Greater Los Angeles Healthcare System
Collaborators
University of California, Los Angeles
search

1. Study Identification

Unique Protocol Identification Number
NCT03566615
Brief Title
Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used
Acronym
ASGE
Official Title
Does the Addition of a Cap Improve the Adenoma Detection Rate During Water Exchange Colonoscopy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
January 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
VA Greater Los Angeles Healthcare System
Collaborators
University of California, Los Angeles

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a study to compare two different, but normally, used methods of colonoscopy in patients that require a routine or repeat colonoscopy. There will be three arms in this study: WE water control, water plus Cap-1, and water plus Cap-2. The patient will prepare himself/herself for the colonoscopy as per normal instructions and he/she will be given the information for the study at that time so that he/she can make a decision to participate in the study. The control method will use water instead of air inserted into the colon. The study method will use a new accessory, a cap that will fit onto the end of the colonoscope plus water during the procedure. This study will also confirm if using the cap method with water is a better way of detecting polyps in the colon and possibly cancer.
Detailed Description
This will be a multi-site, multi-national, unblinded investigators, prospective Random Control Trial (RCT). Randomization (WE, WE Cap-1, WE Cap-2) will be based on computer generated random numbers placed inside opaque sealed envelopes. The envelope (in pre-arranged order) will be opened to reveal the code when the colonoscopist is ready to insert the endoscope to begin the examination. This will be a comparison of two different methods with three arms (WE, WE Cap-1, WE Cap-2) to see which one is better at detecting adenomas. Patients who are willing to participate will sign an informed consent before starting the colonoscopy procedure. Separate parallel randomization will be set up at each site, stratified by investigator and type of colonoscopy (screening or surveillance). Mode of sedation will include unsedated (China, US West Los Angeles VA), minimally sedated (Taiwan), on demand sedation (Italy, Czech Republic, US West Los Angeles VA), conscious sedation (US Sacramento VA and Palo Alto VA) or full sedation with propofol (Taiwan). Randomization (prepared by statistics consultant) will be carried out by the method of random permuted block design (based on computer generated random numbers) with variable block sizes of 3 and 6. Gender will be used as a stratification factor. Control Method: One arm of the study will include sedated/unsedated colonoscopy with water (WE) as the control method. Residual air in the colon will be removed and water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Study method: The other two arms entail the addition of a simple commercially available accessory to the colonoscopy device: Cap -1 (Disposable Distal Attachment) or Cap-2, fitted to the colonoscope per manufacturer instruction. The two arms include sedated/unsedated colonoscopy with either a Cap-1 plus water or Cap-2 plus water.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colonoscopy, Polyp of Colon
Keywords
colonoscopy, adenoma detection rate, caps

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
1630 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Water
Arm Type
Active Comparator
Arm Description
Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.
Arm Title
CAP-straight
Arm Type
Experimental
Arm Description
A straight transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.
Arm Title
CAP-daisy
Arm Type
Experimental
Arm Description
A daisy cap transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Note: IRB Approval date for the use of Endocuff at St. Barbara Hospital, Iglesias (CA), Italy, was obtained on 3/8/2017. IRB Approval date for the use of Endocuff at Evergreen General Hospital, Taipei, Taiwan, was obtained on 3/18/2021.
Intervention Type
Device
Intervention Name(s)
CAP-straight
Intervention Description
This study is to detect any differences in the detection rate of adenomas using straight caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.
Intervention Type
Device
Intervention Name(s)
CAP-daisy
Intervention Description
This study is to detect any differences in the detection rate of adenomas using daisy caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.
Intervention Type
Other
Intervention Name(s)
water
Intervention Description
using water instead of traditional air insufflation to help insertion
Primary Outcome Measure Information:
Title
Adenoma detection rate
Description
The proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas, or polyps, detected.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Cecal intubation
Description
Visualization of ileocecal valve/appendix orifice and the medial wall of the cecum with colonoscope tip touching floor of cecum
Time Frame
2 hours: Data collected during colonoscopy procedure
Title
Boston bowel preparation score
Description
Three segments (Right, transverse, left colon), each with 0 to 3 (poor to excellent); total scores = sum (10 point scale)
Time Frame
2 hours: Data collected during colonoscopy procedure
Title
Cecal intubation time
Description
Total time from insertion into the anus to arrival in the cecum
Time Frame
2 hours: Data collected during colonoscopy procedure
Title
Visual analogue scale (0=not satisfied, 10=very satisfied)
Description
Patient satisfaction
Time Frame
2 hours: Data collected during colonoscopy procedure
Title
Willing to repeat
Description
Visual analogue scale (0=not willing, 10=willing)
Time Frame
2 hours: Data collected during colonoscopy procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male and female 50-75 yrs of age. Positive screening for Fecal Immunochemical Test (FIT) or Fecal Occult Blood Test (FOBT). Subjects willing to undergo routine screening and surveillance colonoscopy. Exclusion Criteria: Patients who decline to provide informed consent. Patients known to have colonic obstruction, inflammatory bowel disease, or active GI bleeding requiring interventions. Patients know to have prior history of severe diverticulitis/diverticulosis.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vivek Dixit, PhD
Phone
818-895-9426
Email
vivek.dixit@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Felix W Leung, MD
Phone
818-891-7711
Ext
32520
Email
Felix.Leung@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Felix W Leung, MD
Organizational Affiliation
VA Greater Los Angeles Healthcare System
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sacramento VAMC, VA Northern California Healthcare System
City
Mather
State/Province
California
ZIP/Postal Code
95655-4200
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrew Yen, MD
Email
andrew.yen3@va.gov
First Name & Middle Initial & Last Name & Degree
Joseph W Leung, MD
Email
Joseph.Leung@va.gov
Facility Name
Veterans Affairs Palo Alto Healthcare System
City
Palo Alto
State/Province
California
ZIP/Postal Code
94550
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shai Friedland, MD
Email
shai_friedland@yahoo.com
First Name & Middle Initial & Last Name & Degree
Ramsey Cheung, MD
Email
rcheung@stanford.edu
Facility Name
Xijing Hospital of Digestive Diseases
City
Xian
ZIP/Postal Code
710032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yanglin Pan, MD
Email
panyanglin@gmail.com
Facility Name
St. Barbara Hospital
City
Iglesias
Country
Italy
Individual Site Status
Completed
Facility Name
Dalin Tzu Chi General Hospital
City
Chiayi City
ZIP/Postal Code
622
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yu-Hsi Hsieh, MD
Email
hsieh.yuhsi@msa.hinet.net
Facility Name
Hualien Tzu Chi Hospital
City
Hualien City
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chi-Tan Hu, MD
Email
chitan.hu@msa.hinet.net
Facility Name
Evergreen General Hospital
City
Taipei
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cheng Chiliang, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used

We'll reach out to this number within 24 hrs